Liver function may change how drug KP-001 works in body

NCT ID NCT06619054

First seen Oct 31, 2025 · Last updated May 08, 2026 · Updated 24 times

Summary

This study looked at how the liver's health affects the way a drug called KP-001 moves through the body and its safety. It included 24 adults, some with liver problems and some healthy. Participants received a single dose of KP-001, and researchers measured drug levels in the blood over time. The goal was to understand if liver impairment changes how the drug is processed, which helps guide future dosing.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEPATIC IMPAIRMENT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Sites contracted by Parexel

    San Antonio, Texas, 08103, United States

Conditions

Explore the condition pages connected to this study.